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Abstract 
Insect cellular immune reactions to bacterial infection include nodule formation. Eicosanoids medi-
ate several cellular actions in the nodulation process, including formation of hemocyte microaggre-
gates, an early step. In previous work, we reported that isolated hemocytes produce and secrete 
eicosanoids that influence hemocyte behavior in response to bacterial challenge. We also reported 
that microaggregate formation in response to challenge was mediated by prostaglandins (PGs), but 
not by products of the lipoxygenase (LOX) pathways. In this paper we describe experiments de-
signed to test the idea that exposing isolated hemocytes to lipopolysaccharide (LPS) evokes for-
mation of hemocyte microaggregates and this cellular action is mediated by PGs. Results show that 
isolated hemocyte preparations challenged with LPS formed more hemocyte microaggregates than 
unchallenged preparations (6.9 × 103 microaggregates/ml hemolymph vs. 2.5 × 103 microaggre-
gates/ml hemolymph). LPS challenge stimulated formation of hemocyte microaggregates in a dose 
dependent manner. Experimental groups pretreated with cyclooxygenase inhibitors produced fewer 
hemocyte microaggregates in response to LPS challenge than untreated control groups. The for-
mation of hemocyte microaggregates was not influenced by LOX inhibitors. Furthermore, the influ-
ence of dexamethasone was reversed by supplementing the experimental groups with the eicosanoid 
precursor fatty acid molecule, arachidonic acid and PGH2. Palmitic acid, which is not substrate for 
eicosanoid biosynthesis, did not reverse the effects of dexamethasone on the formation of mi-
croaggregates. The LOX product 5(S)hydroperoxyeicosa-6E,8Z,11Z,14Z-tetraenoic acid also did not 
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reverse the effects of dexamethasone. These results are consistent with similar investigations per-
formed with bacterial suspensions. We infer that isolated hemocyte preparations recognize and react 
to LPS by forming microaggregates and this reaction is mediated by PGs, but not products of the 
LOX pathway. 
 
Keywords: eicosanoids, prostaglandins, cyclooxygenase, lipopolysaccharide, insect immunity, 
hemocyte microaggregates, Manduca sexta, in vitro 
 
1. Introduction 
 
Insect innate immune reactions to microbial infection are separable into humoral and cel-
lular responses (Lavine and Strand, 2002). Humoral reactions involve induced biosynthe-
sis of antibacterial proteins and enzymes, which appear in the hemolymph of infected 
insects approximately 6–12 h post-infection. Cellular defense responses, mainly phagocy-
tosis, encapsulation, and nodulation, begin immediately as infection is detected. These cel-
lular reactions, during which millions of hemocytes are depleted from circulation, are 
responsible for clearing the bulk of infecting microbes from insect hemolymph circulation 
(Horohov and Dunn, 1982). While the signaling pathways responsible for induced expres-
sion of antibacterial proteins are understood in considerable detail, much less is known 
about signal transduction mechanisms in insect cellular immunity. 
On the basis of work with tobacco hornworms, Manduca sexta, it was hypothesized that 
insect cellular immune reactions responsible for clearing bacterial cells from circulation are 
mediated by eicosanoids (Stanley-Samuelson et al., 1991). Eicosanoids are oxygenated me-
tabolites of certain C20 polyunsaturated fatty acids. Major groups of eicosanoids include 
prostaglandins (PGs; products of the cyclooxygenase (COX) pathways) and various prod-
ucts of lipoxygenase (LOX) pathways, all of which are detailed elsewhere (Stanley, 2000). 
With a view toward identifying specific cellular defense reactions which are mediated by 
eicosanoids, Miller et al. (1994) hypothesized that eicosanoids mediate microaggregation 
(an early phase in nodule formation) and nodulation reactions to bacterial infection. The 
outcomes of experiments with tobacco hornworms supported the hypothesis. Mandato et 
al. (1997) advanced this line with experiments on another insect, larvae of the wax moth, 
Gallaria mellonella. They found that other cellular defense actions, specifically cell spread-
ing (a phase of nodulation) and phagocytosis, also depend on eicosanoids. This hypothesis 
has been tested in several insect species and the results of these tests have uniformly sup-
ported the idea, now formalized as the eicosanoid hypothesis (Howard and Stanley, 1999; 
Stanley, 2000; Stanley et al., 2002). 
The eicosanoid hypothesis opens several lines of investigation into insect cellular im-
munity. One concerns the nature of the microbial cell components that insect immune tis-
sues recognize as foreign. Howard et al. (1998) reported that the intensity of nodulation 
reactions, recorded as numbers of visible nodules, varies considerably according to the 
species of infecting bacteria. Because Gram-negative bacteria evoked intense nodulation 
reactions, it was suggested that the lipopolysaccharide (LPS) component of Gram-negative 
bacteria and certain algal species was responsible for evoking microaggregation and nod-
ulation reactions. Bedick et al. (2000) reported that LPS challenge stimulated nodulation 
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reactions in larvae of the beetle Zophobas atratus. This was not an entirely surprising dis-
covery because specific components of bacterial cell walls, including peptidoglycans 
(Kanost et al., 1988) and LPS (Charalambidis et al., 1995) were already known to stimulate 
defense reactions in insects. However, Bedick et al. (2000) also suggested that cellular re-
actions to LPS were mediated by eicosanoids. Hence, it would appear, as suggested by 
Lavine and Strand (2002) that insect immune surveillance systems recognize foreign infec-
tions and release various signals (including eicosanoids) which act to unleash the entire 
array of immune responses. 
Many details of eicosanoid actions in insect immunity remained unclear. For one, the 
cellular source of eicosanoids responsible for mediating cellular defense reactions had not 
been identified. Biochemical work documented eicosanoid biosynthesis in the two main 
immunity-conferring tissues, fat body (Stanley-Samuelson and Ogg, 1994) and hemocytes 
(Gadelhak et al., 1995). Miller and Stanley (2001) reported that bacterial challenge stimu-
lated isolated tobacco hornworm hemocyte preparations to biosynthesize and secrete eico-
sanoids that influence the behaviors of other hemocytes. This finding supported the idea 
that hemocytes per se are responsible for producing the eicosanoids that mediate cellular 
defense reactions. This work also uncovered an apparent paradox. Earlier research on the 
roles of eicosanoids in insect cellular immune reactions indicated that two major groups of 
eicosanoids, PGs and various LOX products, are crucial mediators of defense reactions. 
Miller and Stanley’s (2001) work, contrarily, indicated that COX products, that is, PGs, but 
not LOX products, are responsible for mediating microaggregation reactions in isolated 
hemocyte preparations. The outcomes of further studies with additional pharmaceutical 
probes of the LOX pathways were consistent with this finding (Phelps et al., 2003). 
The issue of identifying the specific eicosanoid biosynthesis pathways which act in in-
sect immunity takes on additional interest with reports that eicosanoids mediate insect 
immune responses to pathogenic fungi. Dean et al. (2002) first suggested that products of 
the COX and LOX pathways mediate tobacco hornworm cellular reactions of the patho-
genic fungus, Metarhizium anisopliae. The picture became murkier with a subsequent re-
port, also on tobacco hornworms, showing that nodulation reactions to spores of the 
fungus Beauveria bassiana were mediated by LOX products but not by PGs (Lord et al., 
2002). As now understood, the eicosanoid hypothesis stands on firm ground, however, it 
cannot be said with certainty which specific eicosanoids are responsible for signaling any 
given cellular defense action. 
In this paper we report on experiments designed to test the idea that isolated hemocyte 
populations express a specific reaction, microaggregation, to challenge with a specific bac-
terial cell wall component, LPS. The microaggregation reactions are mediated by certain 
PGs, a subset of known COX products, but not by LOX products. 
 
2. Materials and methods 
 
2.1. Organisms 
Eggs of the tobacco hornworm, M. sexta, were provided by Ms. Beverley Pagura (North 
Carolina State University). Larvae were reared on standard culture medium in individual 
cups under semisterile conditions developed by Dunn and Drake (1983). Hemocytes were 
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prepared from fifth instars, age 2–3 days. LPS was prepared from the bacterium, Serratia 
marcescens, as described by Bedick et al. (2000). 
 
2.2. Reagents 
Grace’s Insect Medium and selected eicosanoid biosynthesis inhibitors, including the 
phospholipase A2 inhibitor, dexamethasone w(11β,16α)-9-fluoro-11,17,21-trihydroxy-16-
methylpregna-1,4-diene-3,20-dione], the COX inhibitors indomethacin [1-(p-chloroben-
zoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid], ibuprofen [2-(4-isobutylphenyl) propi-
onic acid], naproxen [6-methoxy-α-methyl-2-naphthaleneacetic acid], the LOX inhibitors 
esculetin [6,7-dihydroxycoumarin] and baicalein [5,6,7-trihydroxy-2-phenyl-4H-1-ben-
zopyran-4-one], and the fatty acid, palmitic acid [hexadecanoic acid], were purchased from 
Sigma Chemical Company (St. Louis, Missouri). Arachidonic acid [5,8,11,14-eicosatetrae-
noic acid], PGH2 and 5(S)-hydroperoxyeicosa-6E,8Z,11Z,14Z-tetraenoic acid (5(S)-HpETE) 
were purchased from Cayman Chemical (Ann Arbor, Michigan). 
 
2.3. Hemolymph collection and preparation 
Second and third day fifth-stadium hornworms were anesthetized by chilling on ice for 15 
min, then surface sterilized by swabbing their exteriors with 95% ethanol. Hemolymph (≈ 
500 μl/larva) was collected by the pericardial puncture procedure described by Horohov 
and Dunn (1982). Briefly, a 20-gauge sterile, siliconized needle was inserted anteriorly at 
the thoracic abdominal junction such that the needle penetrated into the pericardial sinus. 
Freely dripping hemolymph was collected into chilled, sterile polypropylene 1.5-ml cen-
trifuge tubes charged with 500 ml of cold Grace’s Insect Medium. The hemolymph was 
gently mixed with Grace’s Insect Medium by inverting the test tube several times. The 
hemocyte preparations were immediately used in each experiment. 
 
2.4. In vitro assay for hemocyte microaggregate formation 
A sterile 96-well (250 μl per well), flat bottom, polystyrene, micro-titer plate was used for 
each experiment (Becton Dickenson, Lincoln, NJ). Each well was preloaded with 70 μl cold 
Grace’s Insect Medium amended with 2 μl ethanol or a selected pharmaceutical and/or 
fatty acid, PGH2 or 5(S)-HpETE dissolved in 2 μl ethanol. Then 20 μl of hemolymph sus-
pension (≈ 6.4 × 105 cells) was added to each well. The hemocyte preparations were then 
challenged by adding 20 μg LPS (standard dosage) dissolved in 5 μl Grace’s Insect Me-
dium. The micro-titer plate was incubated for selected time periods, specified in Section 3, 
at 26°C on a rotary shaker at 100 rpm. After the selected incubation period, 20 ml of the 
hemocyte preparation was applied to a hemacytometer. After a 3-min settling period, a 
cover slip was applied and the number of hemocyte microaggregates (operationally de-
fined as a cluster of five or more cells) for each sample was determined by direct counting 
with phase contrast optics. 
Test preparations were treated with the PLA2 inhibitor, dexamethasone, or one of the 
COX inhibitors indomethacin, ibuprofen, or naproxen or the 5- and 12-LOX inhibitor, es-
culetin or 5-LOX inhibitor, baicalein dissolved in ethanol. In some experiments, test prep-
arations were also treated with arachidonic acid, palmitic acid, PGH2 or 5(S)-HpETE 
dissolved in ethanol. Test preparations were amended with pharmaceutical products at a 
M I L L E R  A N D  S T A N L E Y ,  C O M P A R A T I V E  B I O C H E M I S T R Y  A N D  P H Y S I O L O G Y  P A R T  A  1 3 7  (2 0 0 4 )  
5 
final concentration of 100 μM. Fatty acids were administered at dosages of 0.2 μg in 2 μl 
ethanol per well preparation (final concentration equals 50 μM). PGH2 and 5(S)-HpETE 
were administered at dosages of 0.2 μg in 2 μl ethanol per well preparation (final concen-
tration equals 50 μM). 
 
2.5. Control experiments 
Negative and positive controls were prepared with each experimental group. To assess the 
response in unchallenged preparations (negative control), preparations were treated with 
2 μl ethanol (drug vehicle) but were not exposed to LPS challenge. Positive control prepa-
rations were treated with 2 μl ethanol, then challenged with 20 μg of LPS in 5 μl of Grace’s 
Insect Medium. After 15 min of incubation the number of microaggregates was assessed 
as described. 
 
2.6. Dose response for LPS 
Hemocyte preparations were divided into seven groups and separately treated with 0.0, 
0.1, 0.5, 1.0, 2.0, 20, and 200 μg of LPS dissolved in 5 μl of Grace’s Insect Medium. The 
preparations were then allowed to incubate for 15 min, after which the number of mi-
croaggregates was assessed as described. 
 
2.7. Time course of hemocyte microaggregation: influence of dexamethasone 
Hemocyte preparations were divided into three groups. One group (negative control) was 
treated with 2 μl of ethanol. The second group was treated with 2 μl of ethanol and the 
third group was treated with dexamethasone in 2 μl of ethanol (100 μM final concentra-
tion). The second and third groups were then challenged with 20 μg of LPS in 5 μl of 
Grace’s Insect Medium. Plates were incubated for 5, 15, 30, 45 and 60 min post challenge. 
At each time point, the number of microaggregates was assessed as described. 
 
2.8. Influence of other eicosanoid biosynthesis inhibitors on hemocyte microaggregation 
Hemocyte preparations were set up as described, then divided into eight groups. One 
group was treated with 2 μl ethanol only (negative control). A second group was first 
treated with 2 μl ethanol then inoculated with 20 μg LPS (positive control). The other 
groups were individually treated with the PLA2 inhibitor, dexamethasone, or one of the 
COX inhibitors indomethacin, ibuprofen, or naproxen, or the LOX inhibitors esculetin or 
baicalein, dissolved in ethanol (final concentration equals 100 μM). Then 20 μg LPS in 5 μl 
Grace’s Insect Medium was introduced into each experimental preparation and incubated 
for 15 min post challenge. After the incubation period the number of microaggregates was 
assessed as described. 
 
2.9. Arachidonic acid and prostagladin H2 rescue experiments 
Negative and positive control groups were set up as previously described. Experimental 
preparations were first treated with dexamethasone in 2 μl ethanol and allowed to incu-
bate for 15 min, then inoculated with 20 μg LPS in 5 μl of Grace’s Insect Medium. Imme-
diately after challenge, the dexamethasone-treated preparations were divided into five 
subgroups. Preparations in the first dexamethasone-treated subgroup received no further 
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treatment. Preparations in the second subgroup were treated with the eicosanoid precur-
sor fatty acid arachidonic acid. Preparations in the third subgroup were treated with pal-
mitic acid, which is not substrate for eicosanoid biosynthesis. Preparations in the fourth 
subgroup were treated with PGH2. Preparations in the fifth subgroup were treated with 
the LOX product 5(S)-HpETE. The preparations were then incubated for 15 min. After in-
cubation, the number of microaggregates was assessed as described. 
 
2.10. Statistical analyses 
Significant treatment effects were confirmed for in vitro hemocyte microaggregates by 
analysis of variance with P ≤ 0.05. Where appropriate, significant differences among treat-
ment means were determined by protected least significant differences (LSD). 
 
3. Results 
 
3.1. Control experiments 
Formation of microaggregates may be influenced by a number of factors, including the 
necessary handling involved with setting up in vitro hemocyte preparations. We consid-
ered the possibility of adventitious microaggregate formation by conducting routine con-
trol experiments. Negative control experiments were meant to reveal the background 
numbers of microaggregates in untreated hemocyte preparations. It can be seen from the 
data presented in table 1 that negative control preparations uniformly yielded approxi-
mately 3 × 103 microaggregates/ml hemolymph. Positive control experiments were de-
signed to assess hemocyte preparation capacity for forming microaggregates. The data in 
table 1 indicate that routine preparations treated with a standard dose of LPS (20 μg in 5 
μl of Grace’s Insect Medium) produced approximately 7 × 103 microaggregates/ml hemo-
lymph. The mean number of microaggregates was significantly different between negative 
and positive control preparations (LSD, P < 0.05). 
 
Table 1. Outcomes of control experiments 
Control treatment Number of microaggregates 
Negative controls (n = 32) 2.56 ± 0.40 
Positive controls (n = 27) 6.94 ± 0.44 
Hemocyte preparations were treated with 2 μl of ethanol, then divided 
into two groups. One group was allowed to incubate without any fur-
ther treatment, while the other group was challenged with a standard 
dose of LPS. Both groups were allowed to incubate for 15 min, then 
the number of microaggregates was assessed. The values (× 103) rep-
resent the mean number of microaggregates/ml hemolymph ± stand-
ard error of the mean (S.E.M.). The mean number of microaggregates 
was significantly different between negative and positive control 
preparations (LSD, P < 0.05). 
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3.2. Dose response for LPS 
The relationship between LPS dose and the number of microaggregates is shown in figure 
1. Increasing doses of LPS were associated with increased numbers of observed mi-
croaggregates, from just less than 3 × 103 microaggregates/ml hemolymph with 0.0 μg LPS, 
to approximately 9 × 103 microaggregates/ml hemolymph with 2.0 μg LPS, and approxi-
mately 12 × 103 microaggregates/ml hemolymph with 200.0 μg LPS per preparation at 15-
min incubation. Mean number of microaggregates was significantly related to LPS. 
 
 
 
Figure 1. The influence of LPS dose on numbers of microaggregates formed by hemocyte 
preparations isolated from the tobacco hornworm, M. sexta. The hemocyte preparations 
were inoculated with the indicated doses of LPS (purified from the bacterium S. mar-
cescens) indicated and allowed to incubate for 15 min. Hemolymph samples were applied 
to a hemacytometer. Numbers of hemocyte microaggregates were determined by direct 
counting. The points indicate the mean number of microaggregates/ml hemolymph (× 103) 
and error bars indicate 1 S.E.M. The numbers in parentheses represent the value of n. 
 
3.3. Time course of hemocyte microaggregations: influence of dexamethasone 
The time course of microaggregation in three groups of hemocyte preparations is dis-
played in figure 2. Ethanol-treated (no LPS) hemocyte preparations yielded approximately 
3 × 103 microaggregates/ml hemolymph at 5 min, which increased to approximately 6 × 103 
microaggregates/ml hemolymph at 60 min. Isolated hemocyte preparations treated with 
LPS yielded significantly more microaggregates, approximately 7 × 103 microaggregates/ 
ml hemolymph at 5 min post challenge and increased to approximately 12 × 103 microag-
gregates/ml hemolymph at 60 min post challenge. Isolated hemocyte preparations pre-
treated with dexamethasone then inoculated with LPS yielded approximately 3 × 103 mi-
croaggregates/ml hemolymph at 5 min post challenge and nearly 3 × 103 microaggregates/ 
ml hemolymph at 60 min post challenge. 
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Figure 2. Time course of microaggregation in M. sexta hemocyte preparations in response 
to LPS challenge. Experimental hemocyte preparations (solid triangles) were treated with 
dexamethasone (Dex-treated), then challenged with LPS. Positive control preparations 
(open circles) were challenged with LPS. Negative control preparations (solid circles) 
were treated with the drug vehicle, ethanol, but were not exposed to LPS challenged. At 
the indicated times post challenge, microaggregation was assessed by direct counting un-
der phase contrast optics. Each point indicates the mean number of microaggregates/ml 
hemolymph (× 103) in each hemocyte preparation and the error bars represent 1 S.E.M. 
The numbers in parentheses represent the value of n. 
 
3.4. Influence of other eicosanoid biosynthesis inhibitors on hemocyte microaggregation 
To dissect the possible roles of COX and LOX pathways in microaggregate formation, he-
mocyte preparations were treated with either standard doses of the COX inhibitors indo-
methacin, ibuprofen, naproxen or the 5-and 12-LOX inhibitor esculetin or with the 5-LOX 
inhibitor baicalein. The data in figure 3 indicate that isolated hemocyte preparations 
treated with COX inhibitors yielded significantly fewer microaggregates than positive con-
trol preparations, on par with negative control preparations. Microaggregate formation 
was not influenced in hemocyte preparations treated with the LOX inhibitors, esculetin 
and baicalein. There were no significant differences among the effects of individual COX 
inhibitors on microaggregation. 
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Figure 3. The influence of individual eicosanoid biosynthesis inhibitors on microaggrega-
tion in response to LPS challenge in hemocyte preparations isolated from the tobacco 
hornworm, M. sexta. Test preparations were first treated with either dexamethasone 
(Dex), or indomethacin (Indo), naproxen (Nap), or esculetin (Esc), or Baicalein (Bai). Con-
trol preparations were treated with ethanol (EtOH). Then all preparations were chal-
lenged with LPS. At 15 min post challenge, microaggregation was assessed. The height of 
the histogram bars represents the mean number of microaggregates/ml hemolymph (× 
103). The error bars represent 1 S.E.M. Histogram bars with the same fill pattern are not 
significantly different from each other (LSD, P < 0.05). The numbers in parentheses repre-
sent the value of n. 
 
3.5. Rescue experiments 
In reaction to LPS challenge, dexamethasone-treated hemocyte preparations produced 
fewer microaggregates than ethanol-treated control preparations. On the model that dex-
amethasone inhibits eicosanoid biosynthesis through its inhibitory effect on PLA2, we rea-
soned that supplementing dexamethasone-treated preparations with arachidonic acid, an 
eicosanoid precursor, would reverse the influence of dexamethasone on microaggregate 
formation. Figure 4 shows that control hemocyte preparations treated with the drug vehi-
cle ethanol, but not LPS, produced less than 2 × 103 microaggregates/ml hemolymph. He-
mocyte preparations challenged with LPS produced significantly more microaggregates/ 
ml hemolymph, approximately 5 × 103 microaggregates/ml hemolymph. As seen previ-
ously, hemocyte preparations treated with dexamethasone then challenged with LPS pro-
duced approximately 2 × 103 microaggregates/ml hemolymph, on par with the negative 
control hemocyte preparations. Arachidonic acid reversed the influence of dexamethasone 
on microaggregate formation. Hemocyte preparations treated with dexamethasone, chal-
lenged with LPS and then treated with arachidonic acid yielded approximately 6 × 103 mi-
croaggregates/ml hemolymph, similar to positive control preparations. Similarly, PGH2 
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reversed the influence of dexamethasone. Hemocyte preparations treated with dexame-
thasone, challenged with LPS and then treated with PGH2 yielded approximately 4 × 103 
microaggregates/ml hemolymph, similar to positive control preparations. Hemocyte prep-
arations treated with dexamethasone, challenged with LPS and then treated with palmitic 
acid produced less than 3 × 103 microaggregates/ml hemolymph, not significantly different 
from negative control hemocyte preparations. Finally, hemocyte preparations treated with 
dexamethasone, challenged with LPS and then treated with the LOX product 5-HpETE 
produced approximately 2.5 × 102 microaggregates/ml hemolymph, not significantly dif-
ferent from negative control hemocyte preparations. 
 
 
 
Figure 4. Arachidonic acid and PGH2 reversed the effects of dexamethasone on mi-
croaggregate formation. Tobacco hornworm hemocyte preparations were treated with 
ethanol (EtOH) or dexamethasone (Dex), then challenged with LPS. Immediately after 
LPS challenge, dexamethasone-treated test preparations were treated with arachidonic 
acid (Dex + AA), PGH2 (Dex + PGH2) or palmitic acid (Dex + PA). At 15 min post challenge, 
the number of microaggregates was assessed. The height of the histogram bars represent 
the mean number of microaggregates/ml hemolymph (× 103) and error bars represent 1 
S.E.M. Histogram bars with the same fill pattern are not significantly different from each 
other (LSD, P < 0.05). The numbers in parentheses represent the value of n. 
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4. Discussion 
 
The data reported in this paper indicate that isolated hemocyte preparations are competent 
to recognize and react to LPS challenge. The data also support the hypothesis that mi-
croaggregation reactions in isolated hemocyte preparations are mediated by certain PGs, 
but not by products of the LOX pathway. Three points of evidence support the hypothesis. 
First, isolated hemocyte preparations challenged with LPS formed more hemocyte mi-
croaggregates than unchallenged preparations. Second, LPS stimulated microaggregate 
formation in a dose dependent manner. Third, isolated hemocyte preparations pretreated 
with the PLA2 inhibitor, dexamethasone, or one of the COX inhibitors, indomethacin, ibu-
profen or naproxen produced fewer hemocyte microaggregates than control preparations. 
The 5-and 12-LOX inhibitors esculetin and 5-LOX inhibitor baicalein did not influence the 
formation of hemocyte microaggregates in this system. Finally, the effects of dexame-
thasone were reversed by treating experimental groups with the eicosanoid precursor fatty 
acid, arachidonic acid. Moreover, treating experimental groups with the PG endoperoxide 
PGH2 reversed the influence of dexamethasone. Palmitic acid, which is not a substrate for 
eicosanoid biosynthesis, did not reverse the influence of dexamethasone on hemocyte mi-
croaggregation. Similarly, the LOX product 5(S)-HpETE did not reverse the influence of 
dexamethasone. 
The results of several lines of experiments support the view that certain PGs, but not 
LOX products, are responsible for mediating hemocyte microaggregation reactions to bac-
terial challenge. Miller and Stanley (2001) found that inhibitors of PLA2, the first step in 
eicosanoid biosynthesis, and various COX inhibitors impaired microaggregation reactions 
to bacterial challenge in isolated hemocyte preparations. Similar experiments with the 5- 
and 12-LOX inhibitor, esculetin, did not influence microaggregation reactions to bacterial 
challenge. Because esculetin inhibited nodulation reactions to bacterial challenge in intact 
tobacco hornworms, Phelps et al. (2003) investigated the influence of other LOX inhibitors 
in isolated hemocyte preparations. They reported that none of the LOX inhibitors impaired 
microaggregation. From these data, it would appear that, at least with respect to challenge 
with whole bacteria, products of the COX, but not LOX, pathways are the key microaggre-
gation mediators. 
This study reveals new detail on the roles of eicosanoids in microaggregation reactions. 
First, isolated hemocyte preparations are competent to recognize purified LPS, a specific 
chemical associated with Gram-negative bacteria and a few algae (Bedick et al., 2000). Sec-
ond, the microaggregation reaction to LPS is mediated by PGs. Third, the reversal of the 
dexamethasone influence on microaggregation by treatments with the PG endoperoxide 
PGH2 yields new understanding on which PGs influence microaggregation reactions. 
The actions of 20:4n–6 (arachidonic acid) and PGH2 in reversing the influence of dexa-
methasone are best understood in terms of the biochemistry of PG biosynthesis, drawn 
from Stanley (2000). PG biosynthesis begins with release of 20:4n–6 from membrane phos-
pholipids, usually by action of a cellular PLA2. The free 20:4n–6 is substrate for metabolism 
via of the COX and LOX pathways. COX is thought to be a constitutively active enzyme 
with two distinct catalytic activities. First, a COX activity catalyzes formation of PGG2. Sec-
ond, a peroxidase activity catalyzes a two-electron reduction of PGG2 to form PGH2. The 
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PGH2 is then substrate for a range of cell- and tissue-specific enzymes responsible for con-
verting PGH2 into several biologically active PGs, including PGD2, PGE2, and PGF2α. Other 
biologically active PGs include PGA2 and Δ12-PGJ2. These products are formed by nonen-
zymatic rearrangements of the primary PGs and are thought to act through cellular mech-
anisms, which are fundamentally different from the actions of PGD2, PGE2, and PGF2α. In 
mammalian cells PGA2 is formed from PGE2, however, Stanley-Samuelson and Ogg (1994) 
found that PGE2 is not converted into PGA2 in tobacco hornworm preparations. It appears 
that PGH2 is converted into PGD2, PGE2, and PGF2α in insect systems. We infer that one or 
a mixture of these three primary PGs are responsible for mediating microaggregate reac-
tions to LPS challenge in isolated hemocyte preparations. 
Free 20:4n–6 can also enter a range of LOX pathways. Gadelhak et al. (1995) character-
ized eicosanoid biosynthesis in tobacco hornworm hemocytes, which revealed that, unlike 
fat body, a LOX product, tentatively identified as 15-hydroxyeicosatetraenoic acid, was the 
predominant eicosanoid produced by hemocytes taken from immunologically naive horn-
worms. While hemocytes certainly produce one or more LOX products, these products do 
not act in microaggregation reactions to bacterial challenge in isolated hemocyte prepara-
tions (Miller and Stanley, 2001; Phelps et al., 2003), nor do they act in reactions to purified 
LPS. 
Pretreating intact insects and isolated hemocyte populations with various inhibitors of 
eicosanoid biosynthesis impairs cellular reactions to immune challenge (Miller et al., 1994; 
Stanley et al., 2002). It may be inferred from this observation that the specific eicosanoids 
responsible for mediating cellular immune reactions are produced after an immune chal-
lenge is registered within an infected insect. Indeed, Jurenka et al. (1999) reported that in-
jecting true armyworms with bacteria led to substantial increases in hemolymph titers of 
PGF2α and several other eicosanoids that are yet to be identified. More recently, Tunaz et 
al. (2003) reported that bacterial challenge stimulated increased PLA2 activity in hemocytes 
from tobacco hornworms. The increased PLA2 activity began approximately 30 s post-in-
fection and lasted approximately 5 min. Yajima et al. (2003) also recorded bacterial-stimu-
lated, transient increases in PLA2 activity in the fly Sarchphaga peregrina. Hence, we infer 
that immune challenge provokes increased eicosanoid biosynthesis. 
The precise roles of eicosanoids in insect immunity remain to be elucidated. However, 
we now have a couple of points of meaningful information. First, PGs and various LOX 
products are important in complete nodulation reactions to fungal, bacterial, and LPS chal-
lenge in whole insects (Miller et al., 1994; Bedick et al., 2000; Stanley et al., 2002). Second, 
eicosanoids of unknown origin mediate cellular reactions to parasitoid eggs in Drosophila 
larvae (Carton et al., 2002). Third, recent information suggests that eicosanoids also act in 
humoral immunity to bacterial challenge. Morishima et al. (1997) reported that indometh-
acin inhibited expression of genes for cecropin and for lysozyme in two Bombyx mori prep-
arations, intact larvae and isolated fat body. Yajima et al. (2003) discovered functional 
linkages between eicosanoid biosynthesis and activation of the immune deficiency pathway 
in Drosophila. Finally, as suggested here, certain PGs, but not LOX products, are responsible 
for mediating microaggregation reactions to LPS challenge in isolated hemocytes. 
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